Clinical Trial Update: CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

View source ↗

Summary

Clinical trial update on CROSSROAD comparing re-induction chemotherapy versus direct radiotherapy for locally advanced nasopharyngeal carcinoma after inadequate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Status: NOT_YET_RECRUITING